Display options
Cite
Silvério D, Gonçalves R, Appelberg R, et al. Advances on the Role and Applications of Interleukin-1 in Tuberculosis. mBio. 2021;e0313421doi: 10.1128/mBio.03134-21.
Silvério, D., Gonçalves, R., Appelberg, R., & Saraiva, M. (2021). Advances on the Role and Applications of Interleukin-1 in Tuberculosis. mBio, e0313421. https://doi.org/10.1128/mBio.03134-21
Silvério, Diogo, et al. "Advances on the Role and Applications of Interleukin-1 in Tuberculosis." mBio vol. (2021): e0313421. doi: https://doi.org/10.1128/mBio.03134-21
Silvério D, Gonçalves R, Appelberg R, Saraiva M. Advances on the Role and Applications of Interleukin-1 in Tuberculosis. mBio. 2021 Nov 23;e0313421. doi: 10.1128/mBio.03134-21. Epub 2021 Nov 23. PMID: 34809460; PMCID: PMC8609357.
Copy Download .nbib Format: NLM
Share it on

mBio. 2021 Nov 23;e0313421. doi: 10.1128/mBio.03134-21. Epub 2021 Nov 23.

Advances on the Role and Applications of Interleukin-1 in Tuberculosis.

mBio

Diogo Silvério, Rute Gonçalves, Rui Appelberg, Margarida Saraiva

Affiliations

  1. i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
  2. IBMC-Instituto de Biologia Molecular e Celular, University of Porto, Porto, Portugal.
  3. Doctoral Program in Molecular and Cell Biology, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
  4. Master's Program in Cell and Molecular Biology, FCUP-Faculdade de Ciências, University of Porto, Porto, Portugal.
  5. ICBAS-Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.

PMID: 34809460 PMCID: PMC8609357 DOI: 10.1128/mBio.03134-21

Abstract

Interleukin-1 (IL-1) is a key player in the immune response to pathogens due to its role in promoting inflammation and recruiting immune cells to the site of infection. In tuberculosis (TB), tight regulation of IL-1 responses is critical to ensure host resistance to infection while preventing immune pathology. In the mouse model of Mycobacterium tuberculosis infection, both IL-1 absence and overproduction result in exacerbated disease and mortality. In humans, several polymorphisms in the

Keywords: host-pathogen interactions; immune response; infectious disease; interleukins; tuberculosis

References

  1. J Infect. 2017 May;74(5):456-465 - PubMed
  2. Microbiol Immunol. 2003;47(11):841-7 - PubMed
  3. Mucosal Immunol. 2016 Sep;9(5):1288-302 - PubMed
  4. EBioMedicine. 2017 Nov;25:112-121 - PubMed
  5. Cell Rep. 2020 May 19;31(7):107634 - PubMed
  6. J Exp Med. 2008 Nov 24;205(12):2791-801 - PubMed
  7. J Clin Invest. 2004 Dec;114(12):1790-9 - PubMed
  8. J Clin Rheumatol. 2007 Aug;13(4):219-20 - PubMed
  9. Cell Microbiol. 2008 Sep;10(9):1866-78 - PubMed
  10. Infect Immun. 2004 Apr;72(4):2400-4 - PubMed
  11. Immunity. 2013 Dec 12;39(6):1003-18 - PubMed
  12. Microbiol Spectr. 2016 Oct;4(5): - PubMed
  13. J Immunol. 2011 Mar 1;186(5):3130-7 - PubMed
  14. Front Immunol. 2019 Jun 25;10:1426 - PubMed
  15. J Transl Med. 2018 Jul 20;16(1):206 - PubMed
  16. J Immunol. 2011 Sep 1;187(5):2540-7 - PubMed
  17. Annu Rev Immunol. 2013;31:475-527 - PubMed
  18. Sci Rep. 2020 Feb 28;10(1):3709 - PubMed
  19. Int J Immunogenet. 2007 Feb;34(1):35-44 - PubMed
  20. PLoS One. 2017 Dec 11;12(12):e0189453 - PubMed
  21. Front Immunol. 2020 May 12;11:891 - PubMed
  22. Eur J Immunol. 2012 Feb;42(2):374-84 - PubMed
  23. J Neuroinflammation. 2012 Sep 17;9:217 - PubMed
  24. PLoS One. 2010 Aug 20;5(8):e12320 - PubMed
  25. Trends Biochem Sci. 2002 Sep;27(9):474-82 - PubMed
  26. J Endotoxin Res. 2005;11(5):281-6 - PubMed
  27. Infect Immun. 2009 Sep;77(9):3992-4001 - PubMed
  28. Lab Invest. 2000 May;80(5):759-67 - PubMed
  29. Immunol Rev. 2018 Jan;281(1):197-232 - PubMed
  30. J Exp Med. 1999 Jun 21;189(12):1863-74 - PubMed
  31. PLoS Pathog. 2014 Oct 16;10(10):e1004426 - PubMed
  32. Immunity. 2019 Apr 16;50(4):778-795 - PubMed
  33. J Infect Dis. 2012 Feb 15;205(4):586-94 - PubMed
  34. Front Mol Biosci. 2019 Oct 14;6:105 - PubMed
  35. mBio. 2018 Sep 18;9(5): - PubMed
  36. J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):213-220 - PubMed
  37. Cell Mol Immunol. 2017 Jan;14(1):22-35 - PubMed
  38. Am J Respir Crit Care Med. 2014 Nov 1;190(9):1053-66 - PubMed
  39. Cell Host Microbe. 2015 Jun 10;17(6):799-810 - PubMed
  40. J Immunol. 2018 Feb 1;200(3):1016-1026 - PubMed
  41. Immunol Rev. 2018 Jan;281(1):8-27 - PubMed
  42. J Immunol. 2013 Apr 15;190(8):4196-204 - PubMed
  43. Tissue Antigens. 2006 Apr;67(4):290-6 - PubMed
  44. Nature. 2014 Jul 3;511(7507):99-103 - PubMed
  45. Front Immunol. 2018 Mar 12;9:438 - PubMed
  46. Eur J Immunol. 2009 Jul;39(7):1914-22 - PubMed
  47. J Immunol. 2016 Dec 15;197(12):4714-4726 - PubMed
  48. J Immunol. 2013 Oct 1;191(7):3514-8 - PubMed
  49. PLoS One. 2012;7(7):e40722 - PubMed
  50. Immunity. 2012 Aug 24;37(2):223-34 - PubMed
  51. Science. 1943 Feb 12;97(2511):165-7 - PubMed
  52. Nat Immunol. 2007 Jun;8(6):610-8 - PubMed
  53. Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1292-303 - PubMed
  54. PLoS Pathog. 2009 Jul;5(7):e1000500 - PubMed
  55. Clin Vaccine Immunol. 2013 Jun;20(6):842-7 - PubMed
  56. J Exp Med. 1979 Sep 19;150(3):709-14 - PubMed
  57. J Exp Med. 2018 Apr 2;215(4):1135-1152 - PubMed
  58. J Immunol. 2016 Mar 15;196(6):2444-9 - PubMed
  59. Nat Immunol. 2013 Jan;14(1):52-60 - PubMed
  60. Cell Microbiol. 2011 Sep;13(9):1371-84 - PubMed
  61. Cell Rep. 2020 Apr 7;31(1):107466 - PubMed
  62. PLoS One. 2014 Jan 27;9(1):e86886 - PubMed
  63. Immun Inflamm Dis. 2013 Oct;1(1):47-62 - PubMed
  64. J Immunol. 2018 Sep 15;201(6):1645-1650 - PubMed
  65. Tuberculosis (Edinb). 2013 Sep;93(5):538-47 - PubMed
  66. J Immunol. 2013 Aug 15;191(4):1732-43 - PubMed
  67. Clin Infect Dis. 2006 Sep 15;43(6):717-22 - PubMed
  68. Cytokine. 2019 Nov;123:154759 - PubMed
  69. Nat Immunol. 2012 Jan 22;13(3):246-54 - PubMed
  70. Tuberculosis (Edinb). 2019 Jan;114:91-102 - PubMed
  71. Mucosal Immunol. 2011 May;4(3):252-60 - PubMed
  72. PLoS One. 2013 Jun 26;8(6):e67277 - PubMed
  73. Nature. 1985 Jun 20-26;315(6021):641-7 - PubMed
  74. Nat Microbiol. 2017 May 15;2:17072 - PubMed
  75. J Clin Tuberc Other Mycobact Dis. 2019 Apr 25;16:100102 - PubMed
  76. Nat Commun. 2020 Apr 23;11(1):1949 - PubMed
  77. Elife. 2018 Nov 16;7: - PubMed
  78. J Immunol. 2016 Aug 15;197(4):1287-97 - PubMed
  79. J Exp Med. 2018 Nov 5;215(11):2919-2935 - PubMed
  80. Cell Microbiol. 2010 Aug;12(8):1046-63 - PubMed
  81. J Immunol. 2007 Jul 15;179(2):1178-89 - PubMed
  82. J Infect Dis. 2000 Sep;182(3):902-8 - PubMed
  83. Blood. 2011 Apr 7;117(14):3720-32 - PubMed
  84. Cell Host Microbe. 2008 Apr 17;3(4):224-32 - PubMed
  85. Nat Rev Drug Discov. 2012 Aug;11(8):633-52 - PubMed
  86. Dis Markers. 2019 Oct 29;2019:7869576 - PubMed
  87. Immunol Rev. 2018 Jan;281(1):57-61 - PubMed
  88. Vaccine. 2011 Feb 1;29(6):1339-46 - PubMed
  89. Nat Rev Microbiol. 2016 Nov;14(11):677-691 - PubMed
  90. Cell Death Dis. 2018 May 24;9(6):624 - PubMed
  91. J Infect Chemother. 2021 Apr;27(4):617-624 - PubMed
  92. J Virol. 2002 Jan;76(1):427-31 - PubMed
  93. Nat Microbiol. 2019 Dec;4(12):2128-2135 - PubMed
  94. Sci Rep. 2019 Feb 21;9(1):2507 - PubMed
  95. Immunobiology. 2010 Sep-Oct;215(9-10):804-11 - PubMed
  96. J Immunol. 2007 Sep 1;179(5):3119-25 - PubMed
  97. J Immunol. 2010 Apr 1;184(7):3326-30 - PubMed
  98. BMC Pulm Med. 2009 May 16;9:21 - PubMed
  99. Immunity. 2015 Dec 15;43(6):1125-36 - PubMed
  100. J Immunol. 2012 Apr 15;188(8):3594-602 - PubMed
  101. Microbiol Immunol. 2001;45(11):743-50 - PubMed
  102. Immunol Rev. 2018 Jan;281(1):28-39 - PubMed
  103. PLoS Pathog. 2013;9(6):e1003407 - PubMed
  104. Int J Clin Exp Pathol. 2018 Nov 01;11(11):5441-5449 - PubMed
  105. Cell Rep. 2020 Jan 7;30(1):124-136.e4 - PubMed
  106. Nat Microbiol. 2018 Oct;3(10):1099-1108 - PubMed
  107. Chest. 2000 Jan;117(1):103-9 - PubMed
  108. Int Immunol. 2012 Oct;24(10):637-44 - PubMed
  109. Cell Host Microbe. 2018 Sep 12;24(3):439-446.e4 - PubMed

Publication Types